Pro Mach Expands Pharmaceutical Packaging Capabilities and Integrated Solution Offering with Acquisition of NJM Packaging
10 May 2016
Pro Mach Expands Pharmaceutical Packaging Capabilities and Integrated Solution Offering with Acquisition of NJM Packaging
NJM Packaging's capabilities are expected to fuel growth in pharmaceutical and contract packaging markets, strengthening one of packaging's most comprehensive product lines and support networks
Pro Mach, Inc. continues to expand its capabilities and strengthen its position in growing markets. The global integrated packaging solutions leader announced today it has acquired North American-based NJM Packaging, a leading single-source provider of pharmaceutical, nutraceutical, and personal care packaging machinery. The addition of NJM expands Pro Mach's footprint in the growing pharmaceutical and contract packaging markets and advances its capabilities as an integrated solutions provider.
NJM, founded in 1915, provides state-of-the-art automated packaging and labeling solutions for multiple industries, but built its reputation as the preferred partner for many of the world's most successful pharmaceutical companies and contract packagers. NJM Packaging is one of the five founding members of the Association for Packaging and Processing Technologies (PMMI) in 1933 and has steadily expanded its capabilities and grown its business. Today, NJM is a worldwide leader in stand-alone solutions and integrated systems for packagers of solid dose and liquid pharmaceuticals, biopharmaceuticals, vitamins, and food supplements.
"We're excited to welcome the NJM Packaging team to Pro Mach," said Mark Anderson, Pro Mach President and CEO. "We anticipate continued strong growth in the pharmaceutical packaging machinery market and NJM is a well-established and highly respected brand that has been manufacturing proven solutions and providing experienced, high value customer support for over a century. NJM complements our strengths as an integrated solutions provider and helps us fill in gaps in our pharmaceutical product portfolio. We will invest in NJM so they can continue providing industry leading solutions and support to their customers."
